Flufenamic acid: Growth modulating effects on human aortic smooth muscle cells in vitro

Journal of Vascular and Interventional Radiology

Volumn 13, Issue 1, 2002, Pages 89-96

  Schöber, Wolfgang ^a   Wiskirchen, Jakub ^a   Kehlbach, Rainer ^a   Gebert, Regina ^a   Rodegerdts, Enno ^a   Betsch, Angelika ^a   Johst, Ursula ^a   Claussen, Claus D ^a   Duda, Stephan H ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Blood vessels; Flufenamic acid; Restenosis; Smooth muscle cells; Stenosis or obstruction

Indexed keywords

FLUFENAMIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN P44;

AORTA MEDIA; ARTICLE; BLOOD VESSEL OCCLUSION; CELL CYCLE; CELL CYCLE G2 PHASE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CLONOGENESIS; COLONY FORMATION; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; WESTERN BLOTTING;

EID: 0036146225     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1051-0443(07)60014-1     Document Type: Article

References (36)

1. Transluminally-placed coil-spring endarterial tube grafts: Long-term patency in canine popliteal artery
2. Restenosis 1 to 24 months after clinically successful coronary balloon angioplasty a necropsy study of 20 patients
3. Restenosis after successful percutaneous transluminal coronary angioplasty: Serial angiographic follow-up of 229 patients
4. Migration of smooth muscle and endothelial cells: Critical events in restenosis
5. Scanning electron microscopy after transluminal angioplasty in normal canine coronary arteries
6. Platelet accumulation in experimental angioplasty: Time course and relation to vascular injury
7. The mechanism of balloon angioplasty
8. Morphology after transluminal angioplasty in human beings
9. Restenosis after arterial angioplasty: A hemorrheologic response to injury
10. The three processes leading to post-PTCA restenosis: Dependence on the lesion substrate
11. Different functions of the platelet-derived growth factor- α and β-receptors for the migration and proliferation of cultured baboon smooth muscle cells
12. Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention
13. Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo
14. Smooth muscle cell proliferation in response to co-culture with venous and arterial endothelial cells
15. Antiproliferative and c-myc mRNA suppressive effects of tranilast on newborn human vascular smooth muscle cells in culture
16. Investigations on the mechanism of action of the antiproliferant and ion channel antagonist flufenamic acid
17. Inhibitory effects of tranilast on proliferation, migration, and collagen synthesis of human vascular smooth muscle cells
18. Effectiveness of tranilast on restenosis after directional coronary atherectomy
19. Local drug delivery for the prevention of restenosis
20. Management of restenosis after coronary intervention
21. Collaborative overview of randomised trials of antiplatelet therapy II Maintenance of vascular graft or arterial patency by antiplatelet therapy
22. Noncoronary vascular stenting
23. Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty
24. Mechanismen der re-stenosierung nach angioplastie
25. Involvement of the immune system in human atherogenesis
26. Anti-inflammatory stent coatings: Dexamethasone and related compounds
27. Effects of non-steroidal anti-inflammatory drugs on polymorphonuclear leukocyte functions in vitro: Focus of fenamates
28. Effects of diclofenac on isradipine pharmacokinetics and platelet aggregation in volunteers
29. Anti-inflammatory drugs in experimental atherosclerosis. Part 4: Inhibition of atherosclerosis in vivo and thromboxane synthesis and platelet aggregation in vitro
30. Blockers of platelet-derived growth factor-activated nonselective cation channel inhibit cell proliferation
31. Platelet derived growth factor promotes smooth muscle cell migration and intimal thickening in a rat model of balloon angioplasty
32. The mitogen-activated protein kinase signal transduction pathway
33. The MAPK signaling cascade
34. Activation of mitogen activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury
35. Animal models for atherosclerosis, restenosis, and endovascular graft research